Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection

Kristopher P. Croome, David D. Lee, Justin M. Burns, Dana K. Perry, Justin H Nguyen, Andrew P. Keaveny, Hani M. Wadei, C. Burcin Taner

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction and aim. Many transplant programs have expanded eligibility to include patients previously ineligible because of advanced age. Outcomes of simultaneous liver-kidney transplantation (SLK) in recipients with advanced age are not known. Material and methods. Data from patients undergoing transplantation between 2002 and 2015 were obtained from the UNOS Standard Analysis and Research file. Results. SLK recipients aged ≥ 65 years (N = 677), SLK recipients aged < 65 years (N = 4517), and recipients of liver transplant alone(LTA) aged ≥ 65 years(N = 8495) were compared. Recipient characteristics were similar between the SLK groups. Similar patient and graft survival were observed in SLK recipients aged ≥ 65 years compared to SLK recipients aged < 65 years and LTA recipients aged ≥ 65 years. Importantly, in a subgroup analysis, superior survival was seen in the SLK group aged ≥ 65 years compared to LTA recipients aged ≥ 65 years who underwent dialysis in the week prior to transplantation (p < 0.001). A prediction model of patient survival was developed for the SLK group aged ≥ 65 years with predictors including: age ≥ 70 years (3 points), calculated MELD score (-1 to 2 points), and recipient ventilator status at the time of SLK (4 points). The risk score predicted patient survival, with a significantly inferior survival seen in patients with a score ≥ 4 (p < 0.001). Conclusions. Age should not be used as a contraindication for SLK transplantation. The validated scoring system provides a guide for patient selection and can be used when evaluating elderly patients for SLK transplantation listing.

Original languageEnglish (US)
Pages (from-to)870-880
Number of pages11
JournalAnnals of Hepatology
Volume15
Issue number6
DOIs
StatePublished - Nov 1 2016

Fingerprint

Liver Transplantation
Kidney Transplantation
Patient Selection
Transplantation
Survival
Liver
Graft Survival
Mechanical Ventilators
Survival Analysis
Dialysis
Transplants

Keywords

  • Combined transplant
  • SLK

ASJC Scopus subject areas

  • Hepatology

Cite this

Simultaneous liver and kidney transplantation in elderly patients : Outcomes and validation of a clinical risk score for patient selection. / Croome, Kristopher P.; Lee, David D.; Burns, Justin M.; Perry, Dana K.; Nguyen, Justin H; Keaveny, Andrew P.; Wadei, Hani M.; Taner, C. Burcin.

In: Annals of Hepatology, Vol. 15, No. 6, 01.11.2016, p. 870-880.

Research output: Contribution to journalArticle

Croome, Kristopher P. ; Lee, David D. ; Burns, Justin M. ; Perry, Dana K. ; Nguyen, Justin H ; Keaveny, Andrew P. ; Wadei, Hani M. ; Taner, C. Burcin. / Simultaneous liver and kidney transplantation in elderly patients : Outcomes and validation of a clinical risk score for patient selection. In: Annals of Hepatology. 2016 ; Vol. 15, No. 6. pp. 870-880.
@article{9c348a6fd6d7449caecf0686768da37c,
title = "Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection",
abstract = "Introduction and aim. Many transplant programs have expanded eligibility to include patients previously ineligible because of advanced age. Outcomes of simultaneous liver-kidney transplantation (SLK) in recipients with advanced age are not known. Material and methods. Data from patients undergoing transplantation between 2002 and 2015 were obtained from the UNOS Standard Analysis and Research file. Results. SLK recipients aged ≥ 65 years (N = 677), SLK recipients aged < 65 years (N = 4517), and recipients of liver transplant alone(LTA) aged ≥ 65 years(N = 8495) were compared. Recipient characteristics were similar between the SLK groups. Similar patient and graft survival were observed in SLK recipients aged ≥ 65 years compared to SLK recipients aged < 65 years and LTA recipients aged ≥ 65 years. Importantly, in a subgroup analysis, superior survival was seen in the SLK group aged ≥ 65 years compared to LTA recipients aged ≥ 65 years who underwent dialysis in the week prior to transplantation (p < 0.001). A prediction model of patient survival was developed for the SLK group aged ≥ 65 years with predictors including: age ≥ 70 years (3 points), calculated MELD score (-1 to 2 points), and recipient ventilator status at the time of SLK (4 points). The risk score predicted patient survival, with a significantly inferior survival seen in patients with a score ≥ 4 (p < 0.001). Conclusions. Age should not be used as a contraindication for SLK transplantation. The validated scoring system provides a guide for patient selection and can be used when evaluating elderly patients for SLK transplantation listing.",
keywords = "Combined transplant, SLK",
author = "Croome, {Kristopher P.} and Lee, {David D.} and Burns, {Justin M.} and Perry, {Dana K.} and Nguyen, {Justin H} and Keaveny, {Andrew P.} and Wadei, {Hani M.} and Taner, {C. Burcin}",
year = "2016",
month = "11",
day = "1",
doi = "10.5604/16652681.1222103",
language = "English (US)",
volume = "15",
pages = "870--880",
journal = "Annals of Hepatology",
issn = "1665-2681",
publisher = "Mexican Association of Hepatology",
number = "6",

}

TY - JOUR

T1 - Simultaneous liver and kidney transplantation in elderly patients

T2 - Outcomes and validation of a clinical risk score for patient selection

AU - Croome, Kristopher P.

AU - Lee, David D.

AU - Burns, Justin M.

AU - Perry, Dana K.

AU - Nguyen, Justin H

AU - Keaveny, Andrew P.

AU - Wadei, Hani M.

AU - Taner, C. Burcin

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Introduction and aim. Many transplant programs have expanded eligibility to include patients previously ineligible because of advanced age. Outcomes of simultaneous liver-kidney transplantation (SLK) in recipients with advanced age are not known. Material and methods. Data from patients undergoing transplantation between 2002 and 2015 were obtained from the UNOS Standard Analysis and Research file. Results. SLK recipients aged ≥ 65 years (N = 677), SLK recipients aged < 65 years (N = 4517), and recipients of liver transplant alone(LTA) aged ≥ 65 years(N = 8495) were compared. Recipient characteristics were similar between the SLK groups. Similar patient and graft survival were observed in SLK recipients aged ≥ 65 years compared to SLK recipients aged < 65 years and LTA recipients aged ≥ 65 years. Importantly, in a subgroup analysis, superior survival was seen in the SLK group aged ≥ 65 years compared to LTA recipients aged ≥ 65 years who underwent dialysis in the week prior to transplantation (p < 0.001). A prediction model of patient survival was developed for the SLK group aged ≥ 65 years with predictors including: age ≥ 70 years (3 points), calculated MELD score (-1 to 2 points), and recipient ventilator status at the time of SLK (4 points). The risk score predicted patient survival, with a significantly inferior survival seen in patients with a score ≥ 4 (p < 0.001). Conclusions. Age should not be used as a contraindication for SLK transplantation. The validated scoring system provides a guide for patient selection and can be used when evaluating elderly patients for SLK transplantation listing.

AB - Introduction and aim. Many transplant programs have expanded eligibility to include patients previously ineligible because of advanced age. Outcomes of simultaneous liver-kidney transplantation (SLK) in recipients with advanced age are not known. Material and methods. Data from patients undergoing transplantation between 2002 and 2015 were obtained from the UNOS Standard Analysis and Research file. Results. SLK recipients aged ≥ 65 years (N = 677), SLK recipients aged < 65 years (N = 4517), and recipients of liver transplant alone(LTA) aged ≥ 65 years(N = 8495) were compared. Recipient characteristics were similar between the SLK groups. Similar patient and graft survival were observed in SLK recipients aged ≥ 65 years compared to SLK recipients aged < 65 years and LTA recipients aged ≥ 65 years. Importantly, in a subgroup analysis, superior survival was seen in the SLK group aged ≥ 65 years compared to LTA recipients aged ≥ 65 years who underwent dialysis in the week prior to transplantation (p < 0.001). A prediction model of patient survival was developed for the SLK group aged ≥ 65 years with predictors including: age ≥ 70 years (3 points), calculated MELD score (-1 to 2 points), and recipient ventilator status at the time of SLK (4 points). The risk score predicted patient survival, with a significantly inferior survival seen in patients with a score ≥ 4 (p < 0.001). Conclusions. Age should not be used as a contraindication for SLK transplantation. The validated scoring system provides a guide for patient selection and can be used when evaluating elderly patients for SLK transplantation listing.

KW - Combined transplant

KW - SLK

UR - http://www.scopus.com/inward/record.url?scp=84995554117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995554117&partnerID=8YFLogxK

U2 - 10.5604/16652681.1222103

DO - 10.5604/16652681.1222103

M3 - Article

C2 - 27740520

AN - SCOPUS:84995554117

VL - 15

SP - 870

EP - 880

JO - Annals of Hepatology

JF - Annals of Hepatology

SN - 1665-2681

IS - 6

ER -